What is Elekta (EKTAb)?
Elekta is a Swedish company specializing in medical devices and software for cancer treatment and brain disorders. The company develops advanced radiotherapy, radiosurgery, and brachytherapy equipment used in oncology centers and hospitals globally. Elekta's product range includes linear accelerators, treatment planning systems, and clinical software designed to improve precision and patient outcomes in radiation therapy. The company supports healthcare providers with solutions that integrate imaging, treatment delivery, and data management. Elekta emphasizes innovation and collaboration with medical professionals to develop technologies that address complex clinical needs. The company operates worldwide, offering services such as training, maintenance, and technical support. Elekta's focus includes enhancing treatment accuracy, workflow efficiency, and patient safety. Its strategic initiatives involve expanding its product portfolio and advancing digital health solutions in oncology care.
Elekta Stock Price Today: Live Overview
The price today is shaped by live market activity, with Elekta trading at kr56.25. Its price fluctuated from kr55.85 to kr57.15, showing a daily percentage change of -1.9315%.
FAQ: Elekta (EKTAb)
What is the current price of EKTAb stock?
The latest trading price is kr56.25.
Does EKTAb pay dividends?
Dividends are paid by the company via cash distributions (if applicable).
Does EKTAb have a formal corporate presence or regional headquarters in the UAE?
The company operates in the UAE through a subsidiary located in DIFC.
What is EKTAb best known for?
The company is most famous for its advanced radiation therapy and oncology solutions.
What assets are typically shown together with EKTAb?
Commonly shown alongside EKTAb: Veeva Systems Inc, Siemens Healthineers AG, ClearPoint Neuro Inc
Latest shares articles



